![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Packaging & Labelling
Chronicled launches blockchain-registered supply chain and pharmaceutical packaging
San Francisco-based blockchain and IoT company, Chronicled, has launched its CryptoSeal prototype for immutable supply chain provenance and the secure movement of physical assets,...
Industry Reports
CSL Behring Presents Positive Results from CSL112 Phase 2b Trial
CSL Limited -At the American Heart Association (AHA) Scientific Sessions in New Orleans, Louisiana, held on 15 November 2016, CSL Behring announced positive results...
Clinical Trials
Selexis SA and OSE Immunotherapeutics Collaborate to Advance Development of Immunotherapies for Cancer and Autoimmune Diseases
Selexis SA, a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, and OSE Immunotherapeutics SA announced the...
Drug Research
Cytori Granted FDA Orphan Drug Designation for ECCS-50 in Scleroderma
Cytori Therapeutics, Inc. announced that the US FDA Office of Orphan Products Development (OOPD) has granted Cytori an orphan drug designation for cryopreserved or...
Packaging & Labelling
Xellia Pharmaceuticals Commences Packaging and Distribution Operations at Cleveland Site after Successful FDA Inspection
Xellia Pharmaceuticals a specialty pharmaceutical company focusing on providing important anti-infective treatments against serious and often life-threatening infections, has received notice from the US...
News
CPhI & P-MEC India gets bigger with an exclusive ‘India Pharma Week 2016’
UBM India, India's leading exhibition organizer, is all set to host CPhI & P-MEC India 2016, one of the world’s leading pharmaceutical networking event...
News
Biothera Pharmaceuticals Preclinical Data Further Validate Mechanism of its Phase 2 Cancer Immunotherapy, Imprime PGG
Biothera Pharmaceuticals Inc will present new preclinical data that further validate the ability of its Phase 2 cancer immunotherapy drug Imprime PGG to induce...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read